secwatch / observer
8-K filed June 24, 2025, 7:59 PM ET ticker JAGX CIK 0001585608
debt confidence high sentiment neutral materiality 0.50

Jaguar Health, Inc. (JAGX): debt financing — Jaguar Health extends $2.57M convertible note maturity to Jan 30, 2026; issues new warrants at $2.70 strike

Jaguar Health, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Jaguar Health, Inc. incurred convertible notes of approximately $2.57 million aggregate principal amount with Participating Investors at 6% per annum maturing January 30, 2026.

Instrument
convertible notes
Principal
approximately $2.57 million aggregate principal amount
Counterparty
Participating Investors
Rate
6% per annum
Maturity
January 30, 2026
Event
incurrence
Exact text from the filing
On June 24, 2025, the Company entered into note exchange and warrant purchase agreements (the “Exchange Agreements”) with certain of the Original Investors (the “Participating Investors”), pursuant to which the Company agreed to (a) issue and sell (i) approximately $2.57 million aggregate principal amount of new 6% convertible promissory notes (the “Replacement Notes”), in exchange for the cancellation of the Original Notes held by the Participating Investors
View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-145742
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.